Fecal Microbiota Transplantation for Treatment of Inflammatory Bowel Disease: From Immune Response to Mechanism
10.3969/j.issn.1008-7125.2021.06.008
- Author:
Xiaocui CHEN
1
;
Yang SUN
1
;
Yinglei MIAO
1
Author Information
1. Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical College
- Publication Type:Journal Article
- Keywords:
Fecal Microbiota Transplantation;
Gut Microbiota;
Immune Responses;
Inflammatory Bowel Disease;
Mechanisms
- From:
Chinese Journal of Gastroenterology
2021;26(6):358-362
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease (IBD) is a chronic, recurrent, nonspecific inflammatory disease of gastrointestinal tract, and includes ulcerative colitis (UC) and Crohn's disease (CD). Many studies have shown that gut microbiota and its mediated immune responses are the key factors driving the development of IBD. Fecal microbiota transplantation (FMT) is widely recognized as a new and potentially effective method for the treatment of IBD, but the mechanism is unclear. This article reviewed the current application of FMT in IBD, the immune response and the microbiota-immune interaction mechanism after FMT for the treatment of IBD, so as to discuss the potential mechanism of FMT in IBD.
